| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| asp0819 | calcium-activated potassium channel kca3.1 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Fibromyalgia[MeSHID:D005356] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||